7DUN
Crystal structure of Fab fragment of Daratumumab
Experimental procedure
Experimental method | MAD |
Source type | SYNCHROTRON |
Source details | SSRF BEAMLINE BL17U |
Synchrotron site | SSRF |
Beamline | BL17U |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2020-09-23 |
Detector | DECTRIS EIGER2 X 16M |
Wavelength(s) | 0.9798 |
Spacegroup name | P 65 2 2 |
Unit cell lengths | 89.905, 89.905, 217.477 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 31.258 - 1.607 |
R-factor | 0.2056 |
Rwork | 0.205 |
R-free | 0.21790 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4cmh |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHENIX |
Refinement software | PHENIX (1.14_3260) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 1.640 |
High resolution limit [Å] | 1.600 | 1.600 |
Rmerge | 0.100 | |
Number of reflections | 68212 | 68212 |
<I/σ(I)> | 30.5 | |
Completeness [%] | 100.0 | |
Redundancy | 17 | |
CC(1/2) | 0.996 | 0.996 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | EVAPORATION, RECRYSTALLIZATION | 291 | 0.2M Potassium phosphate monobasic, 20% w/v Polyethylene glycol 3350 |